Literature DB >> 20629711

Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson's disease in southern China.

Y Zheng1, Y Liu, Q Wu, H Hong, H Zhou, J Chen, H Wang, W Xian, J Li, Z Liu, Z Pei, L Chen.   

Abstract

BACKGROUND: Leucine-rich repeat kinase 2 (LRRK2) S1647T has been identified as a risk variant for Parkinson's disease (PD) in Han Chinese.
METHODS: To replicate the association of LRRK2 S1647T with risk of PD, we conducted a case-control study of this variant involving 406 PD subjects and 412 controls from southern mainland China.
RESULTS: The results showed that the frequency of A allele was higher in patients with PD (OR=1.238, 95% CI: 1.015-1.510, P=0.035) compared to controls. In a multivariate logistic regression analysis with the disease group (patients with PD vs. controls) as the dependent variable and genotype as an independent factor adjusting for the effect of age and gender, the homozygous S1647T genotype (AA) was associated with an increased risk of PD (OR=1.815, 95% CI:1.270-2.594, P=0.001). The pooled analysis of present data and the data from the previous work demonstrated that the frequency of A allele was higher in patients with PD (OR=1.2, 95% CI: 1.09-1.32, P<0.0001).
CONCLUSIONS: LRRK2 S1647T increases the risk of Parkinson's disease in southern China.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20629711     DOI: 10.1111/j.1468-1331.2010.03164.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson's disease in a Han-Chinese population in south-eastern China.

Authors:  Jiangping Cai; Yi Lin; Wanjin Chen; Qifang Lin; Bin Cai; Ning Wang; Weihong Zheng
Journal:  Neurol Sci       Date:  2013-04-30       Impact factor: 3.307

2.  Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.

Authors:  Beomsue Kim; Myung-Soon Yang; Dongjoo Choi; Jong-Hyeon Kim; Hye-Sun Kim; Wongi Seol; Sangdun Choi; Ilo Jou; Eun-Young Kim; Eun-Hye Joe
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

3.  The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials.

Authors:  Anett Illés; Dóra Csabán; Zoltán Grosz; Péter Balicza; András Gézsi; Viktor Molnár; Renáta Bencsik; Anikó Gál; Péter Klivényi; Maria Judit Molnar
Journal:  Front Genet       Date:  2019-10-31       Impact factor: 4.599

4.  The LRRK2 signaling network converges on a centriolar phospho-Rab10/RILPL1 complex to cause deficits in centrosome cohesion and cell polarization.

Authors:  Antonio Jesús Lara Ordóñez; Rachel Fasiczka; Belén Fernández; Yahaira Naaldijk; Elena Fdez; Marian Blanca Ramírez; Sébastien Phan; Daniela Boassa; Sabine Hilfiker
Journal:  Biol Open       Date:  2022-07-29       Impact factor: 2.643

Review 5.  Structural Insights and Development of LRRK2 Inhibitors for Parkinson's Disease in the Last Decade.

Authors:  Gunjan Thakur; Vikas Kumar; Keun Woo Lee; Chungkil Won
Journal:  Genes (Basel)       Date:  2022-08-11       Impact factor: 4.141

6.  Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding.

Authors:  Alexia F Kalogeropulou; Elena Purlyte; Francesca Tonelli; Sven M Lange; Melanie Wightman; Alan R Prescott; Shalini Padmanabhan; Esther Sammler; Dario R Alessi
Journal:  Biochem J       Date:  2022-09-16       Impact factor: 3.766

7.  Cognitive Impairments in LRRK2-Related Parkinson's Disease: A Study in Chinese Individuals.

Authors:  Yifan Zheng; Zhong Pei; Yanmei Liu; Hongyan Zhou; Wenbiao Xian; Yingying Fang; Ling Chen; Qi Wu
Journal:  Behav Neurol       Date:  2015-08-06       Impact factor: 3.342

Review 8.  The Role of LRRK2 in Neurodegeneration of Parkinson Disease.

Authors:  Qin Rui; Haibo Ni; Di Li; Rong Gao; Gang Chen
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Dynamic interaction of genetic risk factors and cocaine abuse in the background of Parkinsonism - a case report.

Authors:  Anett Illés; Péter Balicza; Viktor Molnár; Renáta Bencsik; István Szilvási; Maria Judit Molnar
Journal:  BMC Neurol       Date:  2019-10-28       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.